FIELD: medicine.
SUBSTANCE: topical gel composition for treating erythema or a related symptom contains brimonidine 0.4 wt % to 0.6 wt %, preferentially in the form of brimonidine tartrate, a gelatinising agent, and at least one polyol. The topical application of the gel composition on the skin involved in erythema or having a manifestation of the related symptom has an effect on a serum or plasma profile of brimonidine with an average Cmax approximately 54±28 pcg/ml or less and an average AUC0-24h approximately 568±277 pcg·h/ml or less.
EFFECT: safe and effective treatment of erythema causing no inadequate drug-related side effects.
19 cl, 3 dwg, 5 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMPROVED METHODS AND COMPOSITIONS FOR SAFE AND EFFECTIVE TREATMENT OF TELANGIECTASIA | 2011 |
|
RU2535008C2 |
| OPHTHALMIC COMPOSITION FOR TREATMENT OF GLAUCOMA COMPLICATED BY MYOPIA | 2023 |
|
RU2808891C1 |
| TREATMENT OF INFLAMMATORY DAMAGES IN CASE OF ROSAZEA USING IVERMECTIN | 2014 |
|
RU2633481C2 |
| COMBINATION OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS AND NON-STEROID ANTI-INFLAMMATORY DRUG FOR TREATING OR PREVENTING INFLAMMATORY SKIN INJURY | 2010 |
|
RU2532388C2 |
| INJECTED COMBINATION OF AGONISTS OF ADRENERGIC RECEPTORS WITH FILLERS FOR REDUCTION OF SKIN RESPONSES TO INJECTION | 2010 |
|
RU2530604C2 |
| COMBINATION OF AVERMECTINE OR MILBEMYCIN WITH ADRENERGIC RECEPTORS FOR TREATING OR PREVENTING DERMATOLOGICAL DISEASES | 2010 |
|
RU2531087C2 |
| METHODS FOR TREATMENT OF GAUCHER DISEASE | 2018 |
|
RU2781242C2 |
| SYSTEM FOR DOSED DISTRIBUTION | 2013 |
|
RU2637420C2 |
| METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISEASES | 2016 |
|
RU2691412C2 |
| TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADIN | 2014 |
|
RU2799761C2 |
